|
|
Learning Objectives Following the completion of this conference, attendees should be able to: 1. Discuss immunotherapy’s potential to improve clinical outcomes forpatients with breast cancer. 2. Distinguish key advantages of immunotherapy over conventional chemotherapeutic and targeted treatments. 3. Determine appropriateness of genetic testing for breast cancer risk 4. Integrate into professional practice the most recent clinical advances and key updates of the NCCN Guidelines related to breast cancer 5. Provide patients and caregivers information about their prognosis, treatment options, benefits and harms of treatment, supportive/palliative care measures 6. Evaluate patients for clinical trial participation when appropriate 7. Describe ongoing and planned clinical trials in the adjuvant, neoadjuvant and metastatic settings and counsel appropriately selected patients about the availability of ongoing clinical trials 8. Consider the integration of reconstruction for patients undergoing mastectomy 9. Distinguish the most up-to-date information about staging for breast cancer 10. Review current concepts in Breast Reconstruction 11. Consider new trends and technologies in breast reconstruction 12, Discuss updates to the NCCN guidelines for breast cancer 13. Explain how the new screening updates will impact management of breast cancer care 14. Review past and current clinical trials for IORT |
|
Knowledge Resources, Vassar Brothers Medical Center | 45 Reade Place, Poughkeepsie, NY 12601 | Library: 845.437.3121 | vbmclibrary@health-quest.org | CME Inquiries: 845.483.6013 |